Skip to main content
. 2022 Nov 10;13:1029818. doi: 10.3389/fimmu.2022.1029818

Figure 7.

Figure 7

Overview of the (endo)cannabinoid system and its putative connections to other signaling systems. The figure was adapted and modified from (190) originally licensed under CC-BY, version 4.0. 5-HT, 5-hydroxytryptamine (serotonin) receptor; A2A and A3, adenosine 2A and 3 receptors; ABDH6 and -12, α/β-hydrolase domain containing 6 and 12; CBC, (-)-cannabichromene; CBD, (-)-cannabidiol; CBDV, (-)-cannabidivarin; CBG, (-)-cannabigerol; CBGV, (-)-cannabigerovarin; CBN, (-)-cannabinol; (-)-cis-PET (–),-cis-perrottetinene; COX2, cyclooxygenase-2; DAGL, diacylglycerol lipase; eCB, endocannabinoid; FAAH, fatty acid amide hydrolase; GPR, G protein-coupled receptor; LOX, lipoxygenase; MAGL, monoacylglycerol lipase; NAAA, N-acylethanolamine hydrolyzing acid amidase; NAPE-PLD, N-acyl phosphatidylethanolamine-specific phospholipase D; PPAR, peroxisome proliferator-activated receptor; PTPN22, protein tyrosine phosphatase non-receptor type 22; THC, (-)-trans-Δ9-tetrahydrocannabinol; THCV, (-)-Δ9-tetrahydrocannabivarin; TRP, transient receptor potential ion channel.